drugset / Trial / NCT00546442
Treatment Insulin Resistence in HCV G-1 Patient
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate the effect of treatment of insulin resistance in the response of chronic hepatitis C treatment, mesure as HCV-RNA negative at week 72. 4.3.2 Objetivos secundarios To evaluate the efficacy and safety of treatment with metformine to erradicate the insulin resistance of patients with chornic hepatitis C genotype 1 measure as HOMA-IR \< 2.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | — |
| Subject | Metformin | Small molecule | 2550 mg | — |